Synovial sarcoma presenting with huge mediastinal mass: A case report and review of literature

被引:11
作者
Salah S. [1 ]
Al-Ibraheem A. [2 ]
Daboor A. [3 ]
Al-Hussaini M. [3 ]
机构
[1] Department of Medical Oncology, King Hussein Cancer Center, Amman
[2] Department of Radiology, Nuclear Imaging Division, King Hussein Cancer Center, Amman
[3] Department of Pathology and Laboratory Medicine, King Hussein Cancer Center, Amman
关键词
Chemotherapy; Mediastinal mass; Surgical resection; Synovial sarcoma;
D O I
10.1186/1756-0500-6-240
中图分类号
学科分类号
摘要
Background: Synovial sarcoma presenting in the mediastinum is exceedingly rare. Furthermore, data addressing optimal therapy is limited. Herein we present a case where an attempt to downsize the tumor to a resectable state with chemotherapy was employed. Case presentation. A 32 year female presented with massive pericardial effusion and unresectable huge mediastinal mass. Computed axial tomography scan - guided biopsy with adjunctive immunostains and molecular studies confirmed a diagnosis of synovial sarcoma. Following three cycles of combination Ifosfamide and doxorubicin chemotherapy, no response was demonstrated. The patient refused further therapy and had progression of her disease 4 months following the last cycle. Conclusion: Synovial sarcoma presenting with unresectable mediastinal mass carry a poor prognosis. Up to the best of our knowledge there are only four previous reports where primary chemotherapy was employed, unfortunately; none of these cases had subsequent complete surgical resection. Identification of the best treatment strategy for patients with unresectable disease is warranted. Our case can be of benefit to medical oncologists and thoracic surgeons who might be faced with this unique and exceedingly rare clinical scenario. © 2013 Salah et al.; licensee BioMed Central Ltd.
引用
收藏
相关论文
共 19 条
  • [1] Salter D.M., Pulmonary and thoracic sarcomas, Curr Diagn Pathol, 12, pp. 409-417, (2006)
  • [2] Ducimetiere F., Lurkin A., Ranchere-Vince D., Decouvelaere A.V., Peoc'H M., Istier L., Chalabreysse P., Muller C., Alberti L., Bringuier P.P., Scoazec J.Y., Schott A.M., Bergeron C., Cellier D., Blay J.Y., Ray-Coquard I., Incidence of sarcoma histotypes and molecular subtypes in a prospective epidemiological study with central pathology review and molecular testing, PLoS One, 6, 8, (2011)
  • [3] Paquette M., Truong P.T., Hart J., Jones S.O., Martens B., Christie J.L., Alexander C., Joe H., Primary sarcoma of the mediastinum: A report of 16 cases referred to the British Columbia cancer agency, J Thorac Oncol, 5, 6, pp. 898-906, (2010)
  • [4] Nakagawa Y., Shimizu T., Terakado M., Hiranuma H., Matsumoto K., Takahashi N., Hashimoto S., A case of synovial sarcoma of the mediastinum, Nihon Kokyuki Gakkai Zasshi, 48, 10, pp. 734-738, (2010)
  • [5] Arafah M., Zaidi S.N., Poorly differentiated monophasic synovial sarcoma of the mediastinum, Indian J Pathol Microbiol, 54, 2, pp. 384-387, (2011)
  • [6] Gladish G.W., Sabloff B.M., Munden R.F., Truong M.T., Erasmus J.J., Chasen M.H., Primary thoracic sarcomas, Radiographics, 22, pp. 621-637, (2002)
  • [7] Eilber F.C., Dry S.M., Diagnosis and management of synovial sarcoma, J Surg Oncol, 97, 4, pp. 314-320, (2008)
  • [8] Rossi S., Nascimento A.G., Canal F., Dei Tos A.P., Small round-cell neoplasms of soft tissues: An integrated diagnostic approach, Curr Diagn Pathol, 13, pp. 150-163, (2007)
  • [9] Miettinen M., Limon J., Niezabitowski A., Lasota J., Patterns of keratin polypeptides in 110 biphasic, monophasic, and poorly differentiated synovial sarcomas, Virchows Arch, 437, 3, pp. 275-283, (2000)
  • [10] Hirakawa N., Naka T., Yamamoto I., Fukuda T., Tsuneyoshi M., Overexpression of bcl-2 protein in synovial sarcoma: A comparative study of other soft tissue spindle cell sarcomas and an additional analysis by fluorescence in situ hybridization, Hum Pathol, 27, 10, pp. 1060-1065, (1996)